Global Stem Cells Market: Snapshot
The high unmet medical needs worldwide play a pivotal role in the tremendous growth of the global stem cells market. With the growing prevalence of chronic diseases and malignancies due to the changing lifestyles, stem cells are being highly acknowledged for their treatment. The increasing investments in the research and development of stem cells rendered by several governments worldwide are also augmenting the market. Moreover, the rising popularity of stem cells banking services and expanding medical tourism industry are providing a fillip to the market.
Despite the array of favorable factors, the market growth is hampered by the high cost of treatment. This factor is compounded by the lack of reimbursement policies, which is making stem cell treatment almost unaffordable for patients belonging to low and medium income groups. Furthermore, the increasing cases of unethical harvesting of stem cells are prompting governments to formulate stringent regulations, which in turn are adversely affecting the growth of the market. As per the findings of the report, the global stem cells market was valued at US$62.28 bn in 2015 and is estimated to rise to US$119.51 bn by 2018, expanding at a CAGR of 24.2% from 2012 to 2018.
Download Exclusive Global Strategic Business Report:
Easy Harvesting Procedure of Adult Stem Cells to Promote their Adoption in Research Activities
On the basis of products, adult stem cells will continue to dominate the market until 2018, representing 86.0% of the overall market revenue. The procedures of harvesting adult stem cells are less complicated in adults. Moreover, better acceptance by the human body and lesser probability of contamination during the process of culture are leading to the higher adoption of adult stem cells in a multitude of research activities in the field of regenerative medicine. The induced pluripotent stem cells (iPSC) segment is anticipated to expand at an impressive CAGR of 25.3% during the forecast period.
On the basis of technology, cell acquisition will be the leading segment in terms of revenue in 2015. The acquisition is the foremost step undertaken in obtaining stem cells. The primary role of this step is warranting the leadership of the segment until 2018.
North America to Lead Revenue Generation through 2018
North America will be the leading regional market throughout the forecast period, accounting for 60% of the overall market revenue by 2018. Stem cell facilitates the treatment of certain type of cardiac diseases and neurological disorders which are highly prevalent in the region, particularly in the U.S. This coupled with the availability of only symptomatic treatment for these diseases is triggering the growth of the North America stem cell market. Moreover, looking at the immense benefits offered by stem cells, several governments and organizations are pouring funds into their research and marketing.
Asia Pacific is poised to rise at a CAGR of 25.7% during the same period. Companies involved in clinical research are shifting their base from developed countries to developing countries such as Hong Kong, Singapore, India, and China. This shift can be attributed to factors such as lower cost incurred in clinical trials and expanding pool of patients which makes the patient recruitment easier. Moreover, contract research organizations are increasing in these countries. These factors are, collectively, contributing to the growth of the region.
Some of the key players in the global stem cells market are Advanced Cell Technology, Angel Biotechnology, Bioheart, Biotime Inc., Brainstorm Cell Therapeutics, California Stem Cell Inc., Celgene Corporation Inc., Cellartis AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and Stemcelltechnologies Inc.
Browse Full Research Report on Stem Cells Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.